Delighted to announce that we have entered into a new drug discovery and development collaboration with the University of Oxford. The collaboration will see teams from Apollo and the University of Oxford working together to identify and assess the potential of novel validated therapeutic targets, bringing Apollo’s in-house expertise and resources to Oxford’s world class researchers and delivering faster routes to market for new medicines. The partnership marks our sixth collaboration with a world leading university, further bolstering our scalable R&D platform, and supporting our aim to translate breakthroughs in biology and basic medical research into innovative new medicines. Read the full press release on our website here: https://lnkd.in/eH95J4c5 #UKscience #Collaboration #UniversityofOxford
Looking forward to working with the Apollo team, Richard Mason Kay Penicud Richard Butt, to progress this exciting initiative in Oxford.
This great news, University of Oxford, with its world renowned research expertise aligned with the true innovation at Apollo Therapeutics, the true winner will be patient outcomes. Collaboration is so instrumental in the search for new medicines, and this is a powerful example. #pharma #pharmaceuticalinnovation #biotech #IT #researchanddevelopment #collaboration
Excellent news. Looking forward to this collaboration with the University of Oxford.
Great News Mike. Good to see Apollo teaming up with my former University. I have the upmost respect for Chas Bountra of Keble College and his team at Oxford. I wish the collaboration every success. 👍🏻
Wonderful for Apollo and for Oxford and most importantly for the development of therapeutics for patients in need. Congratulations team.
Glad to see the success continues
Wow - continuing to go from strength to strength! Congrats to all of the Apollo team!
Great news, congratulations Apollo, chas bountra and all.
Well done Richard and the team at apollo
Chief Scientific Officer at Apollo Therapeutics
3moExcited to help to translate great Oxford science into new medicines.